The movement toward transparency is global, touching almost every aspect of society. Whether the topic is NSA eavesdropping in the U.S. or banking practices in the European Union, transparency and accountability go hand in hand. The pharma industry is no different.
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed...
Endo International has appointed Susan Hall, Ph.D. as executive vice president, chief scientific...
The head of the Food and Drug Administration says her agency will add more inspectors in India to better monitor drugs from the country's burgeoning pharmaceutical industry, even as her agency also seeks closer cooperation with Indian regulators.
European Medicines Agency Recommends that Protelos/Osseor Remain Available But with Further RestrictionsFebruary 21, 2014 8:23 am | News | Comments
The European Medicines Agency has concluded its review of Protelos/Osseor and has recommended further restricting the use of the medicine to patients who cannot be treated with other medicines approved for osteoporosis.
Jean-Christophe Tellier, currently UCB’s Executive Vice President, Biopharma Brands and Solutions, will be appointed Chief Executive Officer-Elect and Chairman of the Executive Committee as of March 1, 2014. Jean-Christophe Tellier will also be proposed to be appointed as a member of the Board of Directors at the next Annual General Meeting of Shareholders on April 24, 2014.
The manipulation of clinical research data for a blood pressure drug sold by Novartis Pharma K.K. has led a special squad of Tokyo prosecutors to search the Japanese unit of the Swiss drugmaker as well as the university that conducted the research.
Tokyo prosecutors raided Novartis Pharma K.K. on Wednesday over its alleged use of exaggerated advertising for a blood pressure-lowering drug, following a criminal complaint filed by the health ministry last month.
There's one big reason why the United States has a dearth of execution drugs so acute that some states are considering solutions such as firing squads and gas chambers: Europe's fierce hostility to capital punishment. The phenomenon started nine years ago when the EU banned the export of products used for execution, citing its goal to be the "leading institutional actor and largest donor to the fight against the death penalty."
Leading cancer experts say Europe's antiquated drug regulatory system is stopping children from getting life-saving medicines and are calling for changes that would remove a loophole that allows companies to skip developing medicines for children already approved for adults.
Swiss food and drink giant Nestlé and French cosmetics company L'Oréal have approved a deal to transfer ownership of Swiss dermatology pharmaceuticals company Galderma.
UPS said Tuesday that it has completed its acquisition of Polar Speed, a company that helps deliver temperature-sensitive pharmaceutical supplies in the United Kingdom. Financial terms were not disclosed.
Merck and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes.
Jazz Pharmaceuticals today announced that it has commenced construction of a manufacturing and development facility to be located on a 17-acre site in Monksland, County Roscommon, approximately 75 miles east of the company's Dublin headquarters. This is the first manufacturing facility to be built by Jazz Pharmaceuticals.
AbbVie has announcesd a US$320 million [approximately S$400 million] investment to establish operations in Singapore for small molecule and biologics active drug substance manufacturing.
Today, the U.S. Food and Drug Administration announced that Commissioner Margaret A. Hamburg, M.D. will travel Feb. 10-18 to India to further strengthen cooperation between the FDA and its Indian regulatory counterparts.
GlaxoSmithKline says fourth-quarter earnings nearly tripled and sales rose 5 percent, even as an ongoing investigation hurt business in China.
Authorities in eastern China announced a ban Tuesday on live poultry sales following a spike in the number of people infected with the H7N9 strain of bird flu, with the busy Chinese New Year travel period already under way.
Actavis plc has signed and completed an agreement for Zhejiang Chiral Medicine Chemicals Co., Ltd to acquire Actavis' interest in Actavis (Foshan) Pharmaceuticals Co., Ltd., an Actavis subsidiary based in Foshan, China.
U.S. health regulators said Thursday they are barring imported drugs from an overseas factory operated by Ranbaxy Laboratories, India's largest drugmaker, due to quality control violations.
A spate of bird flu cases since the beginning of the year in China has experts watching closely as millions of people and poultry are on the move ahead of the Lunar New Year holiday, the world's largest annual human migration. China has reported more than 50 H7N9 infections in 2014 after the strain jumped from birds to people for the first time last year.
AstraZeneca and Bristol-Myers Squibb today announced that Xigduo™ (dapagliflozin and metformin hydrochloride in 5mg/850mg and 5mg/1000mg tablets) has been granted Marketing Authorization by the European Commission for the treatment of type 2 diabetes in the European Union (EU).
As we move into 2014 the global pharmaceutical market can breathe a sigh of relief that the worst seems to be behind us. The hit to the marketplace due to patent expiry reached its peak in 2012 when approximately $38 billion in revenue evaporated.
The World Health Organization is set to announce today that India has officially eliminated polio.
The U.S. Pharmacopeial Convention (USP), a nonprofit global health organization that creates and promotes quality standards for medicines, herbal medicines/dietary supplements and food ingredients, today marked the official inauguration of its expanded state-of-the-art laboratory and administrative facility in Shanghai, China.
China's biggest drug distributor says two former executives are the target of a corruption investigation, widening a graft probe that has focused on foreign pharmaceutical makers. A former vice president of state-owned Sinopharm Group Ltd., Shi Jinming, was detained last week by Shanghai...
France's Health Ministry said that sales of Sativex, produced by Britain's GW Pharmaceuticals, will be allowed for the treatment of muscle spasms associated with multiple sclerosis.
Japan's health ministry said Thursday it has filed a criminal complaint against Novartis Pharma, alleging exaggerated advertising for the heart condition and blood-pressure lowering drug Diovan. Novartis Pharma K.K., the local unit of Swiss pharmaceutical group Novartis AG, issued an apology on...
- Page 1